US regulators have approved Renflexis, a biosimilar referencing Johnson & Johnson’s tumour necrosis factor (TNF) blocker Remicade (infliximab), across all eligible indications. More: US green light for Remicade biosimilar Source: News
read morePharma chiefs in Europe are calling on heads of state to reach a prompt decision on the new location for the European Medicines Agency, which is to depart from the UK as a result of Brexit. More: Pharma heads call
read moreBristol-Myers Squibb’s investigational liver disease candidate has hit its targets in a mid-stage trial, supporting further research on the drug as a potential treatment for Nonalcoholic Steatohepatitis (NASH). More: BMS presents promising data for NASH drug Source: News
read moreRegeneron’s Eylea success makes it ‘uniquely exposed’ to Medicare payment shift epalmer Fri, 04/21/2017 – 11:14 More: Regeneron's Eylea success makes it 'uniquely exposed' to Medicare payment shift Source: fierce
read moreGSK told to pay $3M for Chicago attorney’s suicide while on generic Paxil esagonowsky Fri, 04/21/2017 – 10:08 More: GSK told to pay M for Chicago attorney's suicide while on generic Paxil Source: fierce
read moreValeant’s $3,500 sticker on Siliq could trigger a pricing war with Lilly, Novartis tracy Fri, 04/21/2017 – 09:50 More: Valeant's ,500 sticker on Siliq could trigger a pricing war with Lilly, Novartis Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals